SIMONCINI, COSTANZA
 Distribuzione geografica
Continente #
NA - Nord America 2.965
AS - Asia 1.283
EU - Europa 996
SA - Sud America 237
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 6
Totale 5.672
Nazione #
US - Stati Uniti d'America 2.892
SG - Singapore 409
CN - Cina 336
IT - Italia 289
HK - Hong Kong 224
BR - Brasile 199
DE - Germania 173
SE - Svezia 142
VN - Vietnam 113
GB - Regno Unito 84
BG - Bulgaria 83
RU - Federazione Russa 60
FR - Francia 46
CA - Canada 42
CI - Costa d'Avorio 42
TR - Turchia 41
IN - India 39
FI - Finlandia 32
NG - Nigeria 29
JP - Giappone 28
AT - Austria 23
BD - Bangladesh 17
ES - Italia 14
UA - Ucraina 12
ZA - Sudafrica 12
IQ - Iraq 11
MX - Messico 10
AR - Argentina 8
MA - Marocco 7
PL - Polonia 7
PY - Paraguay 7
SN - Senegal 7
EC - Ecuador 6
ID - Indonesia 6
PK - Pakistan 6
UZ - Uzbekistan 6
VE - Venezuela 6
BE - Belgio 5
IR - Iran 5
MY - Malesia 5
SA - Arabia Saudita 5
AU - Australia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EG - Egitto 4
KE - Kenya 4
KR - Corea 4
OM - Oman 4
PH - Filippine 4
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
HN - Honduras 3
IE - Irlanda 3
JM - Giamaica 3
JO - Giordania 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BO - Bolivia 2
CO - Colombia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
NL - Olanda 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
IL - Israele 1
KY - Cayman, isole 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
PA - Panama 1
RO - Romania 1
SO - Somalia 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 5.601
Città #
Ashburn 281
Woodbridge 272
Hong Kong 217
Singapore 210
Fairfield 196
Houston 193
Dallas 192
Chandler 186
Santa Clara 170
San Jose 155
Ann Arbor 107
Beijing 89
Sofia 82
Seattle 79
Shanghai 75
Cambridge 71
New York 63
Milan 59
Serra 58
Florence 52
Los Angeles 52
Wilmington 52
Council Bluffs 46
Abidjan 42
Princeton 38
Boardman 36
Lawrence 33
Ho Chi Minh City 32
Munich 31
Lagos 29
Medford 29
Lauterbourg 28
London 27
Ottawa 25
Frankfurt am Main 23
Tokyo 21
Des Moines 18
Vienna 18
Izmir 16
Istanbul 15
Redondo Beach 15
San Diego 15
Buffalo 14
Ogden 13
Pisa 13
Bremen 12
Jacksonville 12
Columbus 10
Nanjing 10
Redwood City 10
Chennai 9
Dong Ket 9
Hanoi 9
São Paulo 9
Belo Horizonte 8
Helsinki 8
Johannesburg 8
Kent 8
Lancaster 8
Norwalk 8
San Francisco 8
Sheffield 8
Turku 8
Dakar 7
Dearborn 7
Guangzhou 7
Madrid 7
Orem 7
Phoenix 7
Denver 6
Nanchang 6
New Delhi 6
Nuremberg 6
Rio de Janeiro 6
Rome 6
Tashkent 6
The Dalles 6
Toronto 6
Brussels 5
Düsseldorf 5
Guarulhos 5
Haiphong 5
Hebei 5
Hefei 5
Jiaxing 5
Newark 5
Quanzhou 5
Shenyang 5
Stockholm 5
Warsaw 5
Berlin 4
Biên Hòa 4
Brooklyn 4
Chicago 4
Detroit 4
Joinville 4
Kostroma 4
Kunming 4
Lappeenranta 4
Matsumoto 4
Totale 3.846
Nome #
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 247
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 241
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 234
Tetracycline treatment in patients with progressive external ophthalmoplegia. 233
Physical exercise and oxidative stress in muscular dystrophies: is there a good balance? Exercise and oxidative stress in MDs 213
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 210
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 209
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 197
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 195
Drugs and mitochondrial diseases: 40 queries and answers. 183
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 180
Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene 178
The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1 172
CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions 171
Muscle pain in mitochondrial diseases: a picture from the Italian network 167
Disruption of sleep-wake continuum in myotonic dystrophy type 1: Beyond conventional sleep staging 164
Oxidative stress biomarkers in Fabry disease: is there a room for them? 163
Mitochondrial epilepsy: a cross-sectional nationwide Italian survey 162
NEWS and VIEWS: mitochondrial encephalomyopathies 156
Tubular Aggregates Myopathy: case description 156
Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease. 153
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study 149
Clinical features of mtDNA-related syndromes in adulthood 146
Catatonia as prominent feature of stroke-like episode in MELAS 141
Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy 139
Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases 139
A multi-parametric protocol to study exercise intolerance in McArdle's disease 138
Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders 137
Therapeutical Management and Drug Safety in Mitochondrial Diseases—Update 2020 128
A Single mtDNA Deletion in Association with a LMNA Gene New Frameshift Variant: A Case Report 127
Exercise therapy in muscle diseases: open issues and future perspectives 126
Mitochondrial ANT-1 related adPEO leading to cognitive impairment: is there a link? 121
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1 116
null 81
Totale 5.672
Categoria #
all - tutte 17.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022326 0 0 10 20 64 45 11 16 11 10 24 115
2022/2023638 49 97 43 47 74 67 3 59 123 4 72 0
2023/2024378 24 36 37 18 48 61 22 19 7 16 53 37
2024/20251.261 0 34 18 79 153 131 118 62 139 140 124 263
2025/20261.309 119 179 153 115 127 102 211 74 85 96 32 16
2026/2027199 37 74 88 0 0 0 0 0 0 0 0 0
Totale 5.672